Neuro Panel: Wingspan Stent’s Probable Benefits No Longer Outweigh Risks

Recent post-market study data leads FDA’s Neurological Devices panel to conclude that the intracranial stent system, which gained humanitarian device exemption approval in 2005, no longer shows probable benefits outweighing the risks.